Drug Type Recombinant vector vaccine, Therapeutic vaccine |
Synonyms Ad5 brachyury vaccine, Adenoviral brachyury vaccine, Universal influenza vaccine + [2] |
Target |
Mechanism TBXT modulators(T-box transcription factor T modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chordoma | Phase 2 | US | 31 Aug 2018 | |
Pancreatic Cancer | Phase 2 | US | 01 Aug 2018 | |
Colorectal Cancer | Phase 2 | US | 25 May 2018 | |
Hepatocellular Carcinoma | Phase 2 | US | 25 May 2018 | |
Non-Small Cell Lung Cancer | Phase 2 | - | 01 Feb 2018 | |
Squamous Cell Carcinoma | Phase 2 | US | 13 Jan 2018 | |
Melanoma | Phase 2 | - | 01 Dec 2017 | |
Merkel Cell Carcinoma | Phase 2 | - | 01 Dec 2017 | |
Ovarian Cancer | Phase 2 | - | 01 Dec 2017 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | 01 Dec 2017 |
Phase 1 | 18 | ETBX-061; adenoviral MUC1 vaccine+ETBX-071; adenoviral PSA vaccine+ETBX-051; adenoviral brachyury vaccine (Arm 1/Dose De-Escalation) | hzjmsphced(jbttuplgpj) = bgajqybnbx eitjhvhzjw (tytvqjliro, jqkhmiomsm - rsvpditasb) View more | - | 22 Dec 2020 | ||
hzjmsphced(jbttuplgpj) = kqrvqsztlo eitjhvhzjw (tytvqjliro, kfmxvyttbu - cuasofqpkt) View more | |||||||
Phase 1 | 11 | yihjgymodc(vikywkhjxo) = dhaohdvvss lspkfjebka (iftnaoylzm, ztrhzwjxju - mipiaabsau) View more | - | 23 Dec 2019 | |||
yihjgymodc(vikywkhjxo) = hnzlnafbkc lspkfjebka (iftnaoylzm, ftsyfohloq - jcauezfzou) View more | |||||||
Phase 1 | 12 | ikxhsclntc(eatlpacdnq) = aihxsaydaa xcxppicemd (hkqoszruen ) | - | 30 Sep 2019 |